secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0000896264-26-000005
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA prelim FY2025 sales ~$925M (beat guidance); FY2026 guidance $925M-$1B
---------------------------------------------------------------------------

- Preliminary FY2025 net sales of ~$925M, above prior guidance of ~$920M.
- FY2026 net sales guidance of $925M-$1.0B; core USANA nutritional seen at $720-765M (down from ~$777M).
- Hiya segment guided $140-155M (up from ~$132M); Rise Wellness $65-80M (up from ~$16M).
- FY2026 is a 52-week year (one week less than FY2025), impacting core business comparison.
- Rise Wellness margins expected at breakeven in FY2026 due to growth investments; working capital rising at both Hiya and Rise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626426000005/0000896264-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626426000005/usna-20260112.htm
  HTML page:      https://secwatch.observer/filing/0000896264-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer